Sechaba Medical Solutions (Pty) Ltd and Others v Sekete and Others

Gen-Health Medical Scheme (third appellant) was a registered medical scheme with approximately 13,000 members. It was placed in final liquidation on 12 October 2010, having been under curatorship since at least 2008. Sechaba Medical Solutions (Pty) Ltd (first appellant) was the administrator for Gen-Health and was appointed pursuant to a court order to compromise or admit claims by Gen-Health's members in the liquidation. Life Healthcare Group (Pty) Ltd (third respondent), representing 18 medical facilities and hospitals, submitted 19 claims totalling approximately R5 million at a special creditors' meeting on 20 February 2012 for services rendered to Gen-Health's members prior to liquidation. The first respondent, Mr Sekete (assistant master of the high court), admitted these claims as proved claims. Sechaba and Gen-Health brought review proceedings to challenge this decision. The healthcare providers had obtained pre-authorisation from Gen-Health via telephonic confirmation before rendering services to patients who were Gen-Health members. Patients signed admission forms declaring they were paid-up members of Gen-Health and authorizing the healthcare provider to submit accounts to Gen-Health for payment.

• Whether a healthcare provider has a valid claim directly against a medical scheme in liquidation for services rendered to members of that scheme
• Whether the assistant master correctly admitted Life Healthcare's claims as proved claims in the liquidation
• The proper interpretation of section 26(1)(b) of the Medical Schemes Act 131 of 1998 regarding a medical scheme's obligation to 'assume liability for and guarantee the benefits offered to its members'
• The proper interpretation of section 59 of the Medical Schemes Act regarding payment of benefits to suppliers of services
• Whether pre-authorisation by a medical scheme creates a contractual relationship between the healthcare provider and the medical scheme
• The standard of proof required for admission of a claim at a creditors' meeting
• Whether Sechaba had standing to institute review proceedings

1. The appeal was dismissed with costs, such costs to be paid by the first appellant (Sechaba) and the liquidators jointly and severally, the one paying the other to be absolved. 2. No costs in relation to the appeal shall be recovered or paid out of the assets of Gen-Health Medical Scheme.

1. When a medical scheme provides pre-authorisation to a healthcare provider to render services to a member, this creates a contractual relationship between the healthcare provider and the medical scheme whereby the scheme undertakes to pay for the services in accordance with the applicable tariff and its rules. 2. Section 26(1)(b) of the Medical Schemes Act 131 of 1998 requires medical schemes to assume liability for and guarantee benefits by paying healthcare providers directly, not merely by reimbursing members. The use of the term 'guarantee' indicates an obligation to discharge the member's liability to third-party healthcare providers. 3. Section 59(2) of the Medical Schemes Act expressly recognizes that benefits may be owing to suppliers of services and creates an obligation for medical schemes to pay such suppliers directly within 30 days of receiving a claim. 4. At the proof of claims stage in insolvency proceedings, a claimant need only establish a prima facie case by disclosing the essential particulars of the claim. Technical objections are not lightly upheld at this stage as the claim is subject to further scrutiny by the liquidator and potentially by the Master and court at later stages.

The court expressed significant concern about Sechaba's role in the litigation, noting it had no clear interest in opposing Life Healthcare's claims and that such opposition was not in the interests of Gen-Health's members. The court observed that members' interests would be better served by maximizing payments to Life Healthcare, thereby reducing their own outstanding liabilities. The court noted it would have been relatively straightforward to compare Life Healthcare's claims with Gen-Health's records and match them with members' claims to avoid duplication. The court expressed disquiet that time better spent winding up the scheme's affairs was wasted on litigation that appeared not to benefit the members most disadvantaged by the liquidation. The court noted that Mr van der Westhuizen's affidavit was extremely cryptic regarding how Gen-Health dealt with claims by healthcare providers prior to liquidation, and that it was evasive in failing to address evidence about pre-authorisation procedures. The court described the relationship between medical schemes and their administrators as typically so close that 'medical schemes are little more than paper entities with a principal officer, a board of trustees and a bank account,' making them dependent on administrators for daily operations.

This case establishes important principles regarding the obligations of medical schemes to healthcare providers in South African law. It clarifies that medical schemes assume direct liability to healthcare providers, not merely an obligation to reimburse members. This interpretation aligns medical scheme obligations with social and practical realities in South Africa where most people cannot afford to pay medical bills upfront and seek reimbursement. The judgment provides authoritative interpretation of sections 26(1)(b) and 59 of the Medical Schemes Act 131 of 1998, establishing that the 'benefit' contemplated is the act of discharging the member's obligation to the healthcare provider, and that pre-authorisation creates contractual obligations. The case has significant implications for medical scheme liquidations and the rights of healthcare providers to claim directly against medical schemes. It also reinforces the principle that at the proof of claims stage in insolvency proceedings, only prima facie proof is required, with full scrutiny occurring at later stages.